Methylene blue
Methylene Blue, Provayblue (methylene blue) is a small molecule pharmaceutical. Methylene blue was first approved as Provayblue on 2016-04-08. It is used to treat cyanosis, herpes simplex, lithiasis, methemoglobinemia, and poisoning amongst others in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| hyophen | unapproved drug other | 2017-01-05 |
| methylene blue | unapproved drug other | 2024-07-02 |
| methylene blue inj | unapproved drug other | 2023-08-09 |
| phosphasal | unapproved drug other | 2017-01-24 |
| provayblue | New Drug Application | 2024-06-10 |
| urelle | unapproved drug other | 2015-01-13 |
| uretron d/s | unapproved drug other | 2024-05-05 |
| uribel | unapproved drug other | 2023-11-22 |
| uribel tabs | unapproved drug other | 2024-01-22 |
| urimar-t caps | unapproved drug other | 2023-07-06 |
Show 9 more
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
Expiration | Code | ||
|---|---|---|---|
METHYLENE BLUE, PROVAYBLUE, PROVEPHARM SAS | |||
| 2027-01-08 | M-303 | ||
Patent Expiration
No data
ATC Codes
V: Various drug classes in atc
— V03: All other therapeutic products
— V03A: All other therapeutic products
— V03AB: Antidotes
— V03AB17: Methylthioninium chloride
— V04: Diagnostic agents
— V04C: Other diagnostic agents in atc
— V04CG: Gastric secretion test diagnostic agents
— V04CG05: Methylthioninium chloride
HCPCS
Code | Description |
|---|---|
| Q9968 | Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg |
Clinical
Clinical Trials
285 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 3 | — | 1 | 13 | 17 |
| Shock | D012769 | — | R57.1 | — | 6 | 7 | 1 | 3 | 14 |
| Septic shock | D012772 | — | A48.3 | — | 6 | 8 | 1 | 2 | 13 |
| Photochemotherapy | D010778 | — | — | — | — | — | 1 | 5 | 6 |
| Sentinel lymph node biopsy | D021701 | — | — | — | — | 1 | 1 | 4 | 6 |
| Morbid obesity | D009767 | EFO_0001074 | — | 1 | 1 | — | 1 | 4 | 6 |
| Sepsis | D018805 | HP_0100806 | A41.9 | 1 | — | 1 | 1 | 2 | 5 |
| Cleft lip | D002971 | EFO_0003959 | Q36 | — | — | — | 1 | 3 | 4 |
| Vasoplegia | D056987 | — | — | — | 1 | — | 2 | — | 3 |
| Methemoglobinemia | D008708 | — | D74 | 1 | — | — | 1 | 1 | 3 |
Show 14 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Colorectal neoplasms | D015179 | — | — | — | 1 | 1 | — | 7 | 9 |
| Obesity | D009765 | EFO_0001073 | E66.9 | — | — | 1 | — | 7 | 8 |
| Endometrial neoplasms | D016889 | EFO_0004230 | — | — | 1 | 2 | — | 4 | 7 |
| Alzheimer disease | D000544 | EFO_0000249 | F03 | 1 | 3 | 2 | — | — | 6 |
| Carcinoma | D002277 | — | C80.0 | — | — | 1 | — | 4 | 5 |
| Cognitive dysfunction | D060825 | HP_0001268 | G31.84 | — | 1 | 2 | — | 2 | 5 |
| Surgical wound infection | D013530 | — | — | 1 | 2 | 1 | — | 1 | 4 |
| Fistula | D005402 | — | — | — | — | 1 | — | 3 | 4 |
| Stomatitis | D013280 | EFO_1001904 | K12.1 | — | 1 | 2 | — | — | 3 |
| Mucositis | D052016 | EFO_1001898 | — | — | 1 | 2 | — | — | 3 |
Show 25 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Covid-19 | D000086382 | — | — | 4 | 5 | — | — | 2 | 10 |
| Infections | D007239 | EFO_0000544 | — | 1 | 2 | — | — | 7 | 9 |
| Malaria | D008288 | EFO_0001068 | B54 | — | 7 | — | — | — | 7 |
| Communicable diseases | D003141 | — | — | 1 | 2 | — | — | 5 | 7 |
| Diabetes mellitus | D003920 | HP_0000819 | E08-E13 | — | 1 | — | — | 5 | 6 |
| Periapical diseases | D010483 | EFO_0010688 | — | — | 1 | — | — | 3 | 4 |
| Ulcer | D014456 | MPATH_579 | — | 1 | 1 | — | — | 2 | 4 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | 1 | — | — | 2 | 3 |
| Lymphedema | D008209 | HP_0001004 | — | — | 1 | — | — | 2 | 3 |
| Abscess | D000038 | EFO_0003030 | — | 1 | 1 | — | — | 1 | 3 |
Show 33 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Nonvital tooth | D019553 | — | — | 1 | — | — | — | 2 | 3 |
| Sars-cov-2 | D000086402 | — | — | 2 | — | — | — | 1 | 3 |
| Diabetic foot | D017719 | EFO_1001459 | — | 1 | — | — | — | 2 | 3 |
| Dental caries | D003731 | EFO_0003819 | K02 | 1 | — | — | — | 1 | 2 |
| Obstructive jaundice | D041781 | EFO_1001068 | — | 1 | — | — | — | 1 | 2 |
| Jaundice | D007565 | HP_0000952 | R17 | 1 | — | — | — | 1 | 2 |
| Foot ulcer | D016523 | — | — | 1 | — | — | — | 1 | 2 |
| Glucosephosphate dehydrogenase deficiency | D005955 | EFO_0007287 | — | 1 | — | — | — | — | 1 |
| Vulvar diseases | D014845 | — | — | 1 | — | — | — | — | 1 |
| Brain waves | D058256 | EFO_0004357 | — | 1 | — | — | — | — | 1 |
Show 6 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Periodontitis | D010518 | EFO_0000649 | K05.3 | — | — | — | — | 16 | 16 |
| Chronic periodontitis | D055113 | EFO_0006343 | K05.3 | — | — | — | — | 7 | 7 |
| Periodontal diseases | D010510 | — | K05.6 | — | — | — | — | 7 | 7 |
| Polyps | D011127 | EFO_0000662 | — | — | — | — | — | 5 | 5 |
| Postoperative pain | D010149 | — | G89.18 | — | — | — | — | 4 | 4 |
| Inflammatory bowel diseases | D015212 | EFO_0003767 | — | — | — | — | — | 4 | 4 |
| Gastroesophageal reflux | D005764 | EFO_0003948 | K21 | — | — | — | — | 4 | 4 |
| Pilonidal sinus | D010864 | HP_0010769 | L05 | — | — | — | — | 4 | 4 |
| Colonic polyps | D003111 | — | K63.5 | — | — | — | — | 4 | 4 |
| Stomach neoplasms | D013274 | EFO_0003897 | C16 | — | — | — | — | 3 | 3 |
Show 150 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Methylene blue |
| INN | methylthioninium chloride |
| Description | Methylene blue is an organic chloride salt having 3,7-bis(dimethylamino)phenothiazin-5-ium as the counterion. A commonly used dye that also exhibits antioxidant, antimalarial, antidepressant and cardioprotective properties. It has a role as an EC 1.4.3.4 (monoamine oxidase) inhibitor, an acid-base indicator, a fluorochrome, an antidepressant, a cardioprotective agent, an EC 3.1.1.8 (cholinesterase) inhibitor, a histological dye, an EC 4.6.1.2 (guanylate cyclase) inhibitor, an antioxidant, an antimicrobial agent, a neuroprotective agent, a physical tracer and an antimalarial. It contains a 3,7-bis(dimethylamino)phenothiazin-5-ium. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | CN(C)c1ccc2nc3ccc(=[N+](C)C)cc-3sc2c1.O.O.O.[Cl-] |
Identifiers
| PDB | — |
| CAS-ID | 61-73-4 |
| RxCUI | — |
| ChEMBL ID | CHEMBL550495 |
| ChEBI ID | — |
| PubChem CID | 6099 |
| DrugBank | DB09241 |
| UNII ID | 8NAP7826UB (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 73,129 documents
View more details
Safety
Black-box Warning
Black-box warning for: Methylene blue, Methylene blue inj, Provayblue
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
1,269 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use